文献速递细菌感染、耐药与抗菌药物

追踪临床环境中产OXA-232肺炎克雷伯菌ST14的遗传多样性与耐药性短期变化

Tracking short-term changes in the genetic diversity and antimicrobial resistance of OXA-232-producing Klebsiella pneumoniae ST14 in clinical settings.
PubMed 文献 · Clin Microbiol Infect · 2019-05-23

OBJECTIVES: To track stepwise changes in genetic diversity and antimicrobial resistance in rapidly evolving OXA-232-producing Klebsiella pneumoniae ST14, an emerging carbapenem-resistant high-risk clone, in clinical settings. METHODS: Twenty-six K.…

要点

  • 产OXA-232的ST14菌株在1年内通过获得质粒和耐药基因逐步增加耐药谱。
  • 染色体整合IS Ecp1-blaCTX-M-15导致mgrB失活,介导黏菌素耐药。
  • 首次在韩国发现同时对碳青霉烯类和黏菌素耐药的肺炎克雷伯菌ST14。

核心结论

  • 产OXA-232的肺炎克雷伯菌ST14在临床环境中随时间逐步发生耐药进化,可获得碳青霉烯类和黏菌素双重耐药。

主要发现

  • SNP分型鉴定出72个独特SNP位点,将分离株分为三个聚类(I、II和III)。
  • 初始分离株携带两个质粒和18个耐药基因(包括blaOXA-232),对11类抗生素耐药。
  • 随后获得四个其他质粒,携带12个不同耐药基因(包括blaCTX-M-15和strA/B),增加对氨曲南和链霉素的耐药。
  • 聚类III的4株菌发生IS Ecp1-blaCTX-M-15染色体整合,导致mgrB失活,介导黏菌素耐药。
  • 部分获得性基因随时间丢失,但保留的12个耐药基因和mgrB失活使菌株对13类抗生素耐药。

临床怎么用

  • 对产OXA-232的ST14等高危克隆需加强基因组监测,警惕碳青霉烯类和黏菌素双重耐药的出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To track stepwise changes in genetic diversity and antimicrobial resistance in rapidly evolving OXA-232-producing Klebsiella pneumoniae ST14, an emerging carbapenem-resistant high-risk clone, in clinical settings. METHODS: Twenty-six K. pneumoniae ST14 isolates were collected by the Korean Nationwide Surveillance of Antimicrobial Resistance system over the course of 1 year. Isolates were subjected to whole-genome sequencing and MIC determinations using 33 antibiotics from 14 classes. RESULTS: Single-nucleotide polymorphism (SNP) typing identified 72 unique SNP sites spanning the chromosomes of the isolates, dividing them into three clusters (I, II and III). The initial isolate possessed two plasmids with 18 antibiotic-resistance genes, including blaOXA-232, and exhibited resistance to 11 antibiotic classes. Four other plasmids containing 12 different resistance genes, including blaCTX-M-15 and strA/B, were introduced over time, providing additional resistance to aztreonam and streptomycin. Moreover, chromosomal integration of insertion sequence Ecp1-blaCTX-M-15 mediated the inactivation of mgrB responsible for colistin resistance in four isolates from cluster III. To the best of our knowledge, this is the first description of K. pneumoniae ST14 resistant to both carbapenem and colistin in South Korea. Furthermore, although some acquired genes were lost over time, the retention of 12 resistance genes and inactivation of mgrB provided resistance to 13 classes of antibiotics. CONCLUSIONS: We describe stepwise changes in OXA-232-producing K. pneumoniae ST14 in vivo over time in terms of antimicrobial resistance. Our findings contribute to our understanding of the evolution of emerging high-risk K. pneumoniae clones and provide reference data for future outbreaks.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Kim YJ, Kim S, Kim J, et al. Tracking short-term changes in the genetic diversity and antimicrobial resistance of OXA-232-producing Klebsiella pneumoniae ST14 in clinical settings. Clin Microbiol Infect. 2019. PMID: 31128287. doi:10.1016/j.cmi.2019.05.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。